Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Thrombosis

In brief

The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple oral doses of BMS-986141 in healthy subjects.

Key facts

Study ID

NCT02341638

Run by

Bristol-Myers Squibb

People needed

148

Starts

2014-09-01

Expected to finish

2015-09-01

Last updated by the study team

2017-03-31

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
• Body Mass Index (BMI) of 18 to 32 kg/m2, inclusive. BMI=Weight (kg)/[height(m)]2
• Women who are not of childbearing potential (i.e., who are postmenopausal or surgically sterile) and men, ages 18 to 75, inclusive

You may not qualify if…

• Concurrent or use within 2 weeks of study drug administration, of marketed or investigational, drugs as specified in protocol
• Other protocol-defined exclusion criteria could apply

Where it is running

• West Coast Clinical Trials, Llc — Cypress, California, United States
• Ppd Development, Lp — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.